San Diego, 92121, CA,
United States
Bionano Genomics, Inc Technographics
Bionano Genomics, Inc Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Bionano Genomics, Inc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 299 Bionano Genomics, Inc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Bionano Genomics, Inc has purchased the following applications: Sage Intacct for ERP Financial in 2014, Cisco Webex Meetings for Audio Video and Web Conferencing in 2017, DocuSign eSignature for Digital Signing in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Bionano Genomics, Inc is running and its propensity to invest more and deepen its relationship with Sage , Cisco Systems , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Bionano Genomics, Inc revenues, which have grown to $18.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Bionano Genomics, Inc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Bionano Genomics, Inc Tech Stack and Enterprise Applications
Bionano Genomics, Inc ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Sage | Legacy | Sage Intacct | ERP Financial | ERP | n/a | 2014 | 2014 |
In 2014, Bionano Genomics, Inc implemented Sage Intacct for ERP Financial operations. The finance function retained complete ownership of financial statement preparation, management of financial reporting processes, and maintenance of adequate internal control over financial reporting.
The Sage Intacct deployment focused on core general ledger and financial reporting capabilities, adapted to produce financial statements, footnote disclosures, and authoritative accounting position memos. The implementation included historical data integration and validation and structured end user training. Configuration emphasized workflow controls for financial close and reporting automation consistent with ERP Financial expectations.
Integration work included partnering with the administration team to manage the Paychex payroll solution and to design payroll administration, processing, review, and approval workflows. The finance organization used Sage Intacct to support due diligence activities and financing document review for over $100M in venture capital fundraising. Operational coverage centered on finance and administration teams, with the application serving as the primary system for reporting and audit support.
Governance and rollout were led internally, with the implementation completed within a 90 day established timeline and delivered 40 percent under budget, including training and historical data validation. Ongoing controls activities included leading and managing financial statement audits, preparing audit support and footnote disclosures, and maintaining authoritative guidance research and accounting position memoranda.
|
Bionano Genomics, Inc Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Cisco Systems | Legacy | Cisco Webex Meetings | Audio Video and Web Conferencing | Collaboration | n/a | 2017 | 2017 |
In 2017, Bionano Genomics, Inc embedded Cisco Webex Meetings on its corporate website to provide Audio Video and Web Conferencing capability. Cisco Webex Meetings was implemented as the web-facing conferencing channel for webinar delivery, customer demos and remote meeting access.
The implementation uses the Cisco Webex Meetings application to enable standard conferencing modules including scheduled meeting orchestration, real time video and audio, screen sharing, recording and attendee management. Deployment architecture centers on an embedded Webex meeting widget and Webex hosted meeting infrastructure, with host account provisioning and administrative controls managed through the Webex administration console. Configuration includes branded meeting rooms and customized join flows to align the meeting experience with the corporate website.
Operational coverage emphasizes external facing business functions such as marketing led webinars, sales demos and customer support interactions accessed through website meeting entry points. Governance is exercised via Webex meeting policies, host permissions and centralized admin controls to manage attendee access and recording controls.
|
|
|
|
|
Collaboration | Collaboration |
|
2019 | 2019 |
|
Bionano Genomics, Inc Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2022 | 2022 |
In 2022, Bionano Genomics, Inc implemented DocuSign eSignature as a Digital Signing solution embedded on its public website. The deployment surfaces DocuSign eSignature for customer facing document execution, using the application to capture electronic signatures, manage envelope workflows, and present signing pages directly within web sessions.
The integration is scoped to the website and does not reference additional enterprise system integrations. DocuSign eSignature handles signature capture, authentication options, envelope status tracking, and tamper evident audit logs, aligning with typical Digital Signing lifecycle management. Governance leverages the built in audit and authentication features of DocuSign eSignature to support externally initiated signing workflows and retention of signature evidence.
|
Bionano Genomics, Inc CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2021 | 2021 |
|
|
|
|
|
Marketing Automation | CRM |
|
2013 | 2013 |
|
|
|
|
|
Marketing Automation | CRM |
|
2019 | 2019 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
Bionano Genomics, Inc ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Remote Monitoring and Management | ITSM |
|
2020 | 2020 |
|
Bionano Genomics, Inc PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Transactional Email | PaaS |
|
2021 | 2021 |
|
Bionano Genomics, Inc IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
Bionano Genomics, Inc CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2019 | 2019 |
|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2014 | 2014 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2014 | 2014 |
|
IT Decision Makers and Key Stakeholders at Bionano Genomics, Inc
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| CFO | CXO | Finance | ||||
| Controller | Director | Finance |
Apps Being Evaluated by Bionano Genomics, Inc Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||